These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21006490)

  • 1. Activity of helvolic acid against Mycobacterium tuberculosis.
    JENNINGS MA
    Nature; 1945; 156():633. PubMed ID: 21006490
    [No Abstract]   [Full Text] [Related]  

  • 2. A new helvolic acid derivative from an endophytic Fusarium sp. of Ficus carica.
    Liang XA; Ma YM; Zhang HC; Liu R
    Nat Prod Res; 2016 Nov; 30(21):2407-12. PubMed ID: 27265219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antitumor efficacy of antibacterial helvolic acid from Cordyceps taii and cyclophosphamide in a tumor mouse model.
    Xiao JH; Zhang Y; Liang GY; Liu RM; Li XG; Zhang LT; Chen DX; Zhong JJ
    Exp Biol Med (Maywood); 2017 Jan; 242(2):214-222. PubMed ID: 27604096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antituberculosis compounds from a deep-sea-derived fungus Aspergillus sp. SCSIO Ind09F01.
    Luo X; Zhou X; Lin X; Qin X; Zhang T; Wang J; Tu Z; Yang B; Liao S; Tian Y; Pang X; Kaliyaperumal K; Li JL; Tao H; Liu Y
    Nat Prod Res; 2017 Aug; 31(16):1958-1962. PubMed ID: 28068839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of helvolic acid and identification of an unusual C-4-demethylation process distinct from sterol biosynthesis.
    Lv JM; Hu D; Gao H; Kushiro T; Awakawa T; Chen GD; Wang CX; Abe I; Yao XS
    Nat Commun; 2017 Nov; 8(1):1644. PubMed ID: 29158519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergistic antibacterial activities of helvolic acid on multi-drug resistant Staphylococcus aureus.
    Qin L; Li B; Guan J; Zhang G
    Nat Prod Res; 2009; 23(4):309-18. PubMed ID: 19296371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel derivative of helvolic acid from Metarhizium anisopliae grown in medium with insect component.
    Lee SY; Kinoshita H; Ihara F; Igarashi Y; Nihira T
    J Biosci Bioeng; 2008 May; 105(5):476-80. PubMed ID: 18558337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of oxidized low-density lipoprotein metabolism in macrophage J774 by helvolic acid.
    Shinohara C; Hasumi K; Endo A
    Biochim Biophys Acta; 1993 Apr; 1167(3):303-6. PubMed ID: 8481392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protostadienol biosynthesis and metabolism in the pathogenic fungus Aspergillus fumigatus.
    Lodeiro S; Xiong Q; Wilson WK; Ivanova Y; Smith ML; May GS; Matsuda SP
    Org Lett; 2009 Mar; 11(6):1241-4. PubMed ID: 19216560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo genome assembly and annotation of rice sheath rot fungus Sarocladium oryzae reveals genes involved in Helvolic acid and Cerulenin biosynthesis pathways.
    Hittalmani S; Mahesh HB; Mahadevaiah C; Prasannakumar MK
    BMC Genomics; 2016 Mar; 17():271. PubMed ID: 27036298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis of steroidal antibiotic fusidanes: functional analysis of oxidosqualene cyclase and subsequent tailoring enzymes from Aspergillus fumigatus.
    Mitsuguchi H; Seshime Y; Fujii I; Shibuya M; Ebizuka Y; Kushiro T
    J Am Chem Soc; 2009 May; 131(18):6402-11. PubMed ID: 19415934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and functional analysis of the second geranylgeranyl diphosphate synthase gene influencing helvolic acid biosynthesis in Metarhizium anisopliae.
    Singkaravanit S; Kinoshita H; Ihara F; Nihira T
    Appl Microbiol Biotechnol; 2010 Jul; 87(3):1077-88. PubMed ID: 20393706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neomycin activity upon Mycobacterium tuberculosis and other mycobacteria.
    WAKSMAN SA; HUTCHISON D; KATZ E
    Am Rev Tuberc; 1949 Jul; 60(1):78-89. PubMed ID: 18132054
    [No Abstract]   [Full Text] [Related]  

  • 14. Fusidic and helvolic acid inhibition of elongation factor 2 from the archaeon Sulfolobus solfataricus.
    De Vendittis E; De Paola B; Gogliettino MA; Adinolfi BS; Fiengo A; Duvold T; Bocchini V
    Biochemistry; 2002 Dec; 41(50):14879-84. PubMed ID: 12475236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp.
    Van Caekenberghe D
    J Antimicrob Chemother; 1990 Sep; 26(3):381-6. PubMed ID: 2228828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemoresistance of Mycobacterium tuberculosis; general aspects and relation to clinical manifestations and therapy; immunity and allergy in antibacterial-treated tuberculosis].
    NITTI V; CURCI G
    G Ital Chemioter; 1954; 1(3-4):390-421. PubMed ID: 14391652
    [No Abstract]   [Full Text] [Related]  

  • 17. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of resistance of Mycobacterium tuberculosis to phthivazide during therapy].
    MAKEEVA OO
    Probl Tuberk; 1954; 4():35-9. PubMed ID: 13215492
    [No Abstract]   [Full Text] [Related]  

  • 19. [Observation of resistance of m. tuberculosis against rimiform in a patient treated with this drug; preliminary communication].
    NIGOGHOSSIAN GA
    Schweiz Med Wochenschr; 1952 Jul; 82(27):707. PubMed ID: 14950251
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sensitivity of Mycobacterium tuberculosis to isonicotinic acid hydrazide and bactericidal effect of Wrocław shock method].
    BEKIERKUNST A; SZNURA J
    Arch Immunol Ther Exp (Warsz); 1954; 2():37-47. PubMed ID: 13269293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.